
Vivtex is a pre-clinical drug development company that leverages its proprietary GI-ORIS™ technology to create next-generation oral therapeutics. By utilizing intact gastrointestinal tract tissue for automated robotic testing, Vivtex aims to revolutionize drug delivery systems, enabling oral administration of biologics that traditionally require injections. The company partners with leading pharmaceutical and biotech firms to develop innovative oral drug formulations, addressing significant challenges in drug absorption and bioavailability. With a strong leadership team and advanced AI capabilities, Vivtex is positioned to make a substantial impact in the biopharmaceutical industry.

Vivtex is a pre-clinical drug development company that leverages its proprietary GI-ORIS™ technology to create next-generation oral therapeutics. By utilizing intact gastrointestinal tract tissue for automated robotic testing, Vivtex aims to revolutionize drug delivery systems, enabling oral administration of biologics that traditionally require injections. The company partners with leading pharmaceutical and biotech firms to develop innovative oral drug formulations, addressing significant challenges in drug absorption and bioavailability. With a strong leadership team and advanced AI capabilities, Vivtex is positioned to make a substantial impact in the biopharmaceutical industry.